Australia Anemia in Pregnancy Market, By Cause (Folic Acid Deficiency, Iron Deficiency, Vitamin B12 Deficiency and Others), Treatment (Iron Products, Folic Acid Supplementation and Others), Route of Administration (Oral, Intravenous and Intramuscular), Prescribing Weeks (< 13 Weeks, 13-27 Weeks and ≥28 Weeks), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others) Industry Trends and Forecast to 2028
Market Analysis and Insights: Australia Anemia in Pregnancy Market
The anemia in pregnancy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.3% in the forecast period of 2021 to 2028 and is expected to reach USD 266.58 million by 2028. The growing cases of hemodilution in pregnancy and rising strict vegetarian women population is expected to act as a driver for the anemia in pregnancy market.
Anemia is a condition where the body doesn’t have enough red blood cells to carry oxygen to tissues. Anemia during pregnancy is common as the body requires more blood to support the growth of the baby. The normal nutrients taken by a woman are not sufficient when she is pregnant, since there is a high requirement for iron and folate during the second and third trimester of pregnancy. Mild anemia is normally seen in every pregnant woman but the severity rises due to low iron or vitamin levels in the body and from other reasons.
The increasing R& D in new treatment options and advancements in diagnostic procedures is expected to boost the growth of anemia in pregnancy market. The side effects of iron supplements during pregnancy are expected to restraint the anemia in pregnancy market. The rising healthcare expenditure and increasing favorable government support for maternal healthcare is expected to create an opportunity for the anemia in pregnancy market. The stringent rules and regulations is expected to pose a challenge for the anemia in pregnancy market.
The anemia in pregnancy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the anemia in pregnancy market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
The anemia in pregnancy market is segmented based on the cause, treatment, route of administration, prescribing weeks, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of cause, the anemia in pregnancy market is segmented into folic acid deficiency, iron deficiency, vitamin B12 deficiency and others. In 2021, iron deficiency segment is dominating the anemia in pregnancy market as every pregnant woman is at risk of iron deficiency anemia.
- On the basis of treatment, the anemia in pregnancy market is segmented into iron products, folic acid supplementation and others. In 2021, iron products segment is dominating the market as many companies are eagerly participating in iron supplement production due to rising demand.
- On the basis of route of administration, the anemia in pregnancy market is segmented into with oral, intravenous and intramuscular. In 2021, oral segment is dominating the market as they are most convenient and easy route for iron implementation.
- On the basis of prescribing weeks, the anemia in pregnancy market is segmented into <13 weeks, 13-27 weeks and ≥28 weeks. In 2021, ≥28 week’s segment is dominating the market as late second and third trimester requires heavy iron content due to growing fetus requirement.
- On the basis of end user, the anemia in pregnancy market is segmented into hospitals, specialty clinics, home healthcare and others. In 2021, hospitals segment is dominating the market since hospitals are first level check-up center for prior dietary plans and medications.
- On the basis of distribution channel, the anemia in pregnancy market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, hospital pharmacy segment is dominating the market because after routine pregnancy care check-ups medicines are brought in hospital pharmacies.
Growing strategic activities by major market players to enhance the awareness for anemia in pregnancy is boosting the anemia in pregnancy market growth
The anemia in pregnancy market also provides you with detailed market analysis for every country growth in particular anemia in pregnancy market. Additionally, it provides the detail information regarding the anemia in pregnancy market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Anemia in Pregnancy Market Share Analysis
The anemia in pregnancy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Australia anemia in pregnancy market.
The major companies dealing in the Australia anemia in pregnancy market report are Viatris Inc., Aspen Pharmacare Australia Pty Ltd, Pharmacare Laboratories Australia, AFT Pharmaceuticals, Bayer AG, A Nelson & Co, Floradix, BLACKMORES and Care Pharmaceuticals among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies’ worldwide which are also accelerating the anemia in pregnancy market.
- In May 2021, Viatris Inc. announced in their newsroom that company participated in 42nd Annual Global Healthcare Conference of Goldman Sachs which was organized on June, 10, 2021. The chief executive officer and president of the company will be answering any queries related to company put forth by worldwide attended customers. This anticipated in enhancing company’s global recognition.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company footprints in the anemia in pregnancy market which also provides the benefit for organization’s profit growth.